Globitair

KFSH Advances Gene Therapy for Sickle Cell Disease Using Patients’ Own Modified Stem Cells

Financial PostSaudi Arabia

RIYADH, Saudi Arabia, Oct. 23, 2026 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH) is advancing gene therapy for sickle cell disease through a 2026 clinical trial that uses the patient’s own hematopoietic stem cells, genetically modified to address the underlying defect and offer a potential path beyond repeated supportive treatment. The […]

Read the full story at Financial PostOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about Saudi Arabia